Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018

Details for Mechanism ID: 18244
Country/Region: Malawi
Year: 2018
Main Partner: Johns Hopkins University
Main Partner Program: JHPIEGO
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $6,476,430 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $64,732
Care: TB/HIV (HVTB) $25,161
Care: Pediatric Care and Support (PDCS) $99,484
Sexual Prevention: Abstinence/Be Faithful (HVAB) $425,000
Prevention: HIV Testing and Counseling (HVCT) $948,137
Sexual Prevention: Other Sexual Prevention (HVOP) $75,000
Treatment: Adult Treatment (HTXS) $4,328,331
Treatment: Pediatric Treatment (PDTX) $510,585
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTC_TST_DSD By Key Population: FSW, Negative 2019 244
HTC_TST_DSD By Key Population: FSW, Positive 2019 88
HTC_TST_DSD By Key Population: MSM, Negative 2019 113
HTC_TST_DSD By Key Population: MSM, Positive 2019 5
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 25-29, Female, Negative 2019 113
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 25-29, Female, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 25-29, Male, Negative 2019 1,350
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 25-29, Male, Positive 2019 31
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 30-34, Female, Negative 2019 102
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 30-34, Female, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 30-34, Male, Negative 2019 1,154
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 30-34, Male, Positive 2019 49
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 35-39, Female, Negative 2019 74
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 35-39, Female, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 35-39, Male, Negative 2019 988
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 35-39, Male, Positive 2019 46
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 40-49, Female, Negative 2019 42
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 40-49, Female, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 40-49, Male, Negative 2019 1,273
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 40-49, Male, Positive 2019 74
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 25-29, Female, Negative 2019 17
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 25-29, Female, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 25-29, Male, Negative 2019 27
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 25-29, Male, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 30-34, Female, Negative 2019 16
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 30-34, Female, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 30-34, Male, Negative 2019 23
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 30-34, Male, Positive 2019 4
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 35-39, Female, Negative 2019 11
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 35-39, Female, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 35-39, Male, Negative 2019 20
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 35-39, Male, Positive 2019 4
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 40-49, Female, Negative 2019 6
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 40-49, Female, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 40-49, Male, Negative 2019 25
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 40-49, Male, Positive 2019 8
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 25-29, Female, Negative 2019 299
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 25-29, Female, Positive 2019 37
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 25-29, Male, Negative 2019 1,114
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 25-29, Male, Positive 2019 63
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 30-34, Female, Negative 2019 270
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 30-34, Female, Positive 2019 45
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 30-34, Male, Negative 2019 953
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 30-34, Male, Positive 2019 149
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 35-39, Female, Negative 2019 196
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 35-39, Female, Positive 2019 42
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 35-39, Male, Negative 2019 815
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 35-39, Male, Positive 2019 158
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 40-49, Female, Negative 2019 110
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 40-49, Female, Positive 2019 55
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 40-49, Male, Negative 2019 1,051
HTC_TST_DSD HTS_TST_N_DSD_MbMod_Age_Sex_Result 40-49, Male, Positive 2019 301
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 25-29, Female, Negative 2019 104
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 25-29, Female, Positive 2019 16
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 25-29, Male, Negative 2019 275
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 25-29, Male, Positive 2019 22
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 30-34, Female, Negative 2019 95
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 30-34, Female, Positive 2019 20
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 30-34, Male, Negative 2019 235
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 30-34, Male, Positive 2019 51
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 35-39, Female, Negative 2019 68
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 35-39, Female, Positive 2019 18
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 35-39, Male, Negative 2019 201
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 35-39, Male, Positive 2019 54
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 40-49, Female, Negative 2019 38
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 40-49, Female, Positive 2019 24
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 40-49, Male, Negative 2019 260
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 40-49, Male, Positive 2019 103
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 25-29, Female, Negative 2019 243
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 25-29, Female, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 25-29, Male, Negative 2019 865
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 25-29, Male, Positive 2019 3
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 30-34, Female, Negative 2019 219
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 30-34, Female, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 30-34, Male, Negative 2019 739
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 30-34, Male, Positive 2019 9
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 35-39, Female, Negative 2019 159
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 35-39, Female, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 35-39, Male, Negative 2019 633
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 35-39, Male, Positive 2019 9
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 40-49, Female, Negative 2019 91
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 40-49, Female, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 40-49, Male, Negative 2019 815
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 40-49, Male, Positive 2019 40
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 25-29, Female, Negative 2019 4
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 25-29, Male, Negative 2019 150
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 25-29, Male, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 30-34, Female, Negative 2019 4
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 30-34, Male, Negative 2019 128
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 30-34, Male, Positive 2019 6
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 35-39, Female, Negative 2019 3
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 35-39, Male, Negative 2019 109
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 35-39, Male, Positive 2019 6
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 40-49, Female, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 40-49, Male, Negative 2019 141
HTC_TST_DSD HTS_TST_N_DSD_OtrMod_Age_Sex_Result 40-49, Male, Positive 2019 12
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 15-19, Female, Negative 2019 2
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 15-19, Female, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 15-19, Male, Negative 2019 14
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 15-19, Male, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 20-24, Female, Negative 2019 2
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 20-24, Female, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 20-24, Male, Negative 2019 14
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 20-24, Male, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 25-29, Female, Negative 2019 2
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 25-29, Male, Negative 2019 5
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 30-34, Female, Negative 2019 2
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 30-34, Male, Negative 2019 4
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 30-34, Male, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 35-39, Female, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 35-39, Male, Negative 2019 4
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 35-39, Male, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 40-49, Female, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 40-49, Male, Negative 2019 5
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 40-49, Male, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 50+, Male, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 25-29, Female, Negative 2019 3
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 25-29, Male, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 30-34, Female, Negative 2019 2
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 30-34, Male, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 35-39, Female, Negative 2019 2
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 35-39, Male, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 40-49, Female, Negative 2019 2
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 40-49, Male, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 25-29, Female, Negative 2019 946
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 25-29, Female, Positive 2019 146
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 25-29, Male, Negative 2019 1,669
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 25-29, Male, Positive 2019 163
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 30-34, Female, Negative 2019 377
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 30-34, Female, Positive 2019 214
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 30-34, Male, Negative 2019 821
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 30-34, Male, Positive 2019 279
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 35-39, Female, Negative 2019 252
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 35-39, Female, Positive 2019 16
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 35-39, Male, Negative 2019 760
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 35-39, Male, Positive 2019 228
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 40-49, Female, Negative 2019 46
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 40-49, Female, Positive 2019 11
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 40-49, Male, Negative 2019 811
HTC_TST_DSD HTS_TST_N_DSD_VCTMod_Age_Sex_Result 40-49, Male, Positive 2019 422
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 25-29, Female, Negative 2019 1,328
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 25-29, Female, Positive 2019 7
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 25-29, Male, Negative 2019 1,328
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 25-29, Male, Positive 2019 11
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 30-34, Female, Negative 2019 1,196
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 30-34, Female, Positive 2019 9
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 30-34, Male, Negative 2019 1,136
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 30-34, Male, Positive 2019 27
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 35-39, Female, Negative 2019 869
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 35-39, Female, Positive 2019 8
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 35-39, Male, Negative 2019 972
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 35-39, Male, Positive 2019 29
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 40-49, Female, Negative 2019 488
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 40-49, Female, Positive 2019 12
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 40-49, Male, Negative 2019 1,253
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 40-49, Male, Positive 2019 54
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 91,024
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 47
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 7
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 10
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 1
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 10
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 1
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 156
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 23
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 1,211
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 162
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 156
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 23
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 1,211
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 162
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 3
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 51
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 11
HTC_TST_DSD Service Delivery Point (Community) Index Mod: <1, Negative 2019 6
HTC_TST_DSD Service Delivery Point (Community) Index Mod: <1, Positive 2019 1
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 86
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 9
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 5,516
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 122
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 86
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 9
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 5,516
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 122
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 10
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2019 2
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 207
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 35
HTC_TST_DSD Service Delivery Point (Community) Other: 15-19, Female, Negative 2019 20
HTC_TST_DSD Service Delivery Point (Community) Other: 15-19, Female, Positive 2019 3
HTC_TST_DSD Service Delivery Point (Community) Other: 15-19, Male, Negative 2019 1,306
HTC_TST_DSD Service Delivery Point (Community) Other: 15-19, Male, Positive 2019 32
HTC_TST_DSD Service Delivery Point (Community) Other: 20-24, Female, Negative 2019 20
HTC_TST_DSD Service Delivery Point (Community) Other: 20-24, Female, Positive 2019 3
HTC_TST_DSD Service Delivery Point (Community) Other: 20-24, Male, Negative 2019 1,306
HTC_TST_DSD Service Delivery Point (Community) Other: 20-24, Male, Positive 2019 32
HTC_TST_DSD Service Delivery Point (Community) Other: 50+, Male, Negative 2019 28
HTC_TST_DSD Service Delivery Point (Community) Other: 50+, Male, Positive 2019 1
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative 2019 314
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 15-19, Female, Positive 2019 33
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative 2019 2,097
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 15-19, Male, Positive 2019 112
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative 2019 517
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 20-24, Female, Positive 2019 81
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative 2019 2,382
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 20-24, Male, Positive 2019 139
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 50+, Female, Negative 2019 41
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 50+, Male, Negative 2019 192
HTC_TST_DSD Service Delivery Point (Community) VCT Mod: 50+, Male, Positive 2019 49
HTC_TST_DSD Service Delivery Point (Facility) Index: 1-9, Negative 2019 256
HTC_TST_DSD Service Delivery Point (Facility) Index: 1-9, Positive 2019 1
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 56
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 5
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 54
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 5
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 618
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 9
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 835
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 24
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 618
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 9
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 835
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 24
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 4
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 252
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 58
HTC_TST_DSD Service Delivery Point (Facility) Index: <1, Negative 2019 31
HTC_TST_DSD Service Delivery Point (Facility) Index: <1, Positive 2019 3
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 41
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 8
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 100
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 4
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 41
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 8
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 100
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 4
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 1
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 7
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 3,455
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 13
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 749
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 3
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 732
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 3
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 517
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 31
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 1,436
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 31
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 517
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 6
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 1,436
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 32
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 10
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 161
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 3
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: <1, Positive 2019 2
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Negative 2019 767
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Positive 2019 12
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 4
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 4
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 4
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 4
HTC_TST_DSD Service Delivery Point (Facility) VCT: 1-9, Negative 2019 2,664
HTC_TST_DSD Service Delivery Point (Facility) VCT: 1-9, Positive 2019 5
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 580
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 1
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 559
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 1
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 2,492
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 45
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 5,094
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 78
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 2,492
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 41
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 5,094
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 83
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 44
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 246
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 6
HTC_TST_DSD Service Delivery Point (Facility) VCT: <1, Negative 2019 348
HTC_TST_DSD Service Delivery Point (Facility)Other PITC: <1, Negative 2019 452
HTS_SELF_DSD HTS_SELF_N_DSD 2019 112,824
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 15-19, Female, Directly-Assisted 2019 9,070
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 15-19, Female, Unassisted 2019 1,590
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 15-19, Male, Directly-Assisted 2019 7,417
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 15-19, Male, Unassisted 2019 2,952
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 20-24, Female, Directly-Assisted 2019 11,504
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 20-24, Female, Unassisted 2019 1,995
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 20-24, Male, Directly-Assisted 2019 9,188
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 20-24, Male, Unassisted 2019 3,705
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 25-29, Female, Directly-Assisted 2019 2,301
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 25-29, Female, Unassisted 2019 1,995
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 25-29, Male, Directly-Assisted 2019 18,391
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 25-29, Male, Unassisted 2019 3,705
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 30-34, Female, Directly-Assisted 2019 1,013
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 30-34, Female, Unassisted 2019 983
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 30-34, Male, Directly-Assisted 2019 9,179
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 30-34, Male, Unassisted 2019 1,825
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 35-39, Female, Directly-Assisted 2019 1,013
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 35-39, Female, Unassisted 2019 983
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 35-39, Male, Directly-Assisted 2019 9,179
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 35-39, Male, Unassisted 2019 1,825
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 40-49, Female, Directly-Assisted 2019 640
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 40-49, Female, Unassisted 2019 585
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 40-49, Male, Directly-Assisted 2019 5,422
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 40-49, Male, Unassisted 2019 1,086
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 50+, Female, Directly-Assisted 2019 413
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 50+, Female, Unassisted 2019 399
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 50+, Male, Directly-Assisted 2019 3,727
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 50+, Male, Unassisted 2019 741
HTS_SELF_DSD HTS_SELF_N_DSD_HIVSelfTest Directly-Assisted 2019 88,456
HTS_SELF_DSD HTS_SELF_N_DSD_HIVSelfTest Unassisted 2019 24,368
KP_PREV_DSD By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 1,500
KP_PREV_DSD By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 223
KP_PREV_DSD By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 36
KP_PREV_DSD Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 1,759
PP_PREV_DSD Age/sex: 15-19 Female 2019 385
PP_PREV_DSD Age/sex: 15-19 Male 2019 154
PP_PREV_DSD Age/sex: 20-24 Female 2019 847
PP_PREV_DSD Age/sex: 20-24 Male 2019 385
PP_PREV_DSD Age/sex: 50+ Female 2019 304
PP_PREV_DSD Age/sex: 50+ Male 2019 227
PP_PREV_DSD Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 22,698
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 25-29, Female 2019 1,519
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 25-29, Male 2019 1,839
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 30-34, Female 2019 3,693
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 30-34, Male 2019 1,905
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 35-39, Female 2019 4,281
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 35-39, Male 2019 1,670
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 40-49, Female 2019 977
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 40-49, Male 2019 4,512
PP_PREV_DSD Sum of Age/Sex disaggregates 2019 2,302
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 148
TB_ART_DSD Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 21
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 230
TB_ART_DSD Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 21
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 420
TB_PREV_DSD By Age/Sex (Denominator): 15+, Female 2019 2,285
TB_PREV_DSD By Age/Sex (Denominator): 15+, Male 2019 3,592
TB_PREV_DSD By Age/Sex (Denominator): <15, Female 2019 327
TB_PREV_DSD By Age/Sex (Denominator): <15, Male 2019 327
TB_PREV_DSD By Age/Sex (Numerator): 15+, Female 2019 2,057
TB_PREV_DSD By Age/Sex (Numerator): 15+, Male 2019 3,233
TB_PREV_DSD By Age/Sex (Numerator): <15, Female 2019 293
TB_PREV_DSD By Age/Sex (Numerator): <15, Male 2019 293
TB_PREV_DSD TB_PREV_D_DSD_TherapyType_NewExArt_HIV IPT, Life-long ART, Already, Positive 2019 654
TB_PREV_DSD TB_PREV_D_DSD_TherapyType_NewExArt_HIV IPT, Life-long ART, New, Positive 2019 5,877
TB_PREV_DSD TB_PREV_N_DSD_TherapyType_NewExArt_HIV IPT, Life-long ART, Already, Positive 2019 588
TB_PREV_DSD TB_PREV_N_DSD_TherapyType_NewExArt_HIV IPT, Life-long ART, New, Positive 2019 5,288
TB_PREV_DSD The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 5,876
TB_PREV_DSD The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 6,531
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 306
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 296
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 43
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 42
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 481
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 465
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 43
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 42
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 845
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2019 873
TX_CURR_DSD Age/Sex: 10-14 Female 2019 90
TX_CURR_DSD Age/Sex: 10-14 Male 2019 78
TX_CURR_DSD Age/Sex: 15-19 Female 2019 232
TX_CURR_DSD Age/Sex: 15-19 Male 2019 245
TX_CURR_DSD Age/Sex: 20-24 Female 2019 581
TX_CURR_DSD Age/Sex: 20-24 Male 2019 217
TX_CURR_DSD Age/Sex: 50+ Female 2019 1,158
TX_CURR_DSD Age/Sex: 50+ Male 2019 1,257
TX_CURR_DSD Age/Sex: <1 2019 15
TX_CURR_DSD Age/Sex: <1-9 2019 135
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2019 14,154
TX_CURR_DSD Sum of age/sex disaggregates 2019 477
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 25-29, Female, Positive 2019 1,009
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 25-29, Male, Positive 2019 246
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 30-34, Female, Positive 2019 1,574
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 30-34, Male, Positive 2019 558
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 35-39, Female, Positive 2019 1,770
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 35-39, Male, Positive 2019 924
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 40-49, Female, Positive 2019 2,234
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 40-49, Male, Positive 2019 1,831
TX_NEW_DSD Breastfeeding status 2019 242
TX_NEW_DSD By Age/Sex: 1-9 2019 41
TX_NEW_DSD By Age/Sex: 10-14 Female 2019 5
TX_NEW_DSD By Age/Sex: 10-14 Male 2019 6
TX_NEW_DSD By Age/Sex: 15-19 Female 2019 138
TX_NEW_DSD By Age/Sex: 15-19 Male 2019 193
TX_NEW_DSD By Age/Sex: 20-24 Female 2019 180
TX_NEW_DSD By Age/Sex: 20-24 Male 2019 194
TX_NEW_DSD By Age/Sex: 50+ Female 2019 3
TX_NEW_DSD By Age/Sex: 50+ Male 2019 55
TX_NEW_DSD By Age/Sex: <1 2019 17
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 2,228
TX_NEW_DSD Pregnancy status 2019 917
TX_NEW_DSD Sum of Age/Sex disaggregates 2019 774
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 25-29, Female, Positive 2019 74
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 25-29, Male, Positive 2019 99
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 30-34, Female, Positive 2019 89
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 30-34, Male, Positive 2019 234
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 35-39, Female, Positive 2019 84
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 35-39, Male, Positive 2019 246
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 40-49, Female, Positive 2019 107
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 40-49, Male, Positive 2019 463
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 3,564
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 63
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 2,136
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 63
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 220
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 32
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 213
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 32
TX_PVLS_DSD Denominator: Indication: Routine 2019 6,133
TX_PVLS_DSD Denominator: Indication: Targeted 2019 190
TX_PVLS_DSD Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 6,323
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 635
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 630
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,429
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 1,419
TX_RET_DSD Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 66
TX_RET_DSD Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 65
TX_RET_DSD Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 65
TX_RET_DSD Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 64
TX_RET_DSD Denominator by Status: Breastfeeding 2019 6
TX_RET_DSD Denominator by Status: Pregnant 2019 9
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 2,178
TX_RET_DSD Numerator by Status: Breastfeeding 2019 6
TX_RET_DSD Numerator by Status: Pregnant 2019 9
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 2,195
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Female 2019 455
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Male 2019 745
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Female 2019 2,909
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Male 2019 5,521
TX_TB_DSD Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 4,333
TX_TB_DSD Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 5,295
TX_TB_DSD Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 9,628
TX_TB_DSD Number of ART patients who were screened for TB at least once during the reporting period 2019 9,630
TX_TB_DSD TX_TB_D_DSD_TBScreen_NewExistingART_HIV Life-long ART, Already, TB Screen - Negative, Positive 2019 6,655
TX_TB_DSD TX_TB_D_DSD_TBScreen_NewExistingART_HIV Life-long ART, Already, TB Screen - Positive, Positive 2019 74
TX_TB_DSD TX_TB_D_DSD_TBScreen_NewExistingART_HIV Life-long ART, New, TB Screen - Negative, Positive 2019 2,870
TX_TB_DSD TX_TB_D_DSD_TBScreen_NewExistingART_HIV Life-long ART, New, TB Screen - Positive, Positive 2019 31
Cross Cutting Budget Categories and Known Amounts Total: $1,495,128
Key Populations: FSW $41,112
Monitoring and evaluation of SW programs
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Collection and use of strategic information on SWs and clients
Training of health workers and community outreach workers
Key Populations: MSM and TG $232,970
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Training of health workers and community outreach workers
Human Resources for Health $471,046
Adolescent Girls and Young Women (AGYW) $750,000